| Stress-triggered phase separation is an adaptive, evolutionarily tuned response JA Riback, CD Katanski, JL Kear-Scott, EV Pilipenko, AE Rojek, ... Cell 168 (6), 1028-1040. e19, 2017 | 763 | 2017 |
| Reversible, specific, active aggregates of endogenous proteins assemble upon heat stress EWJ Wallace, JL Kear-Scott, EV Pilipenko, MH Schwartz, PR Laskowski, ... Cell 162 (6), 1286-1298, 2015 | 485 | 2015 |
| Differences in narrative language in evaluations of medical students by gender and under-represented minority status AE Rojek, R Khanna, JWL Yim, R Gardner, S Lisker, KE Hauer, C Lucey, ... Journal of general internal medicine 34 (5), 684-691, 2019 | 171 | 2019 |
| Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma JK Jasielec, T Kubicki, N Raje, R Vij, D Reece, J Berdeja, BA Derman, ... Blood, The Journal of the American Society of Hematology 136 (22), 2513-2523, 2020 | 62 | 2020 |
| Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions VM Orellana-Noia, DR Reed, AA McCook, JM Sen, CM Barlow, ... Blood, The Journal of the American Society of Hematology 139 (3), 413-423, 2022 | 60 | 2022 |
| Biology and treatment paradigms in T cell acute lymphoblastic leukemia in older adolescents and adults AA Patel, J Thomas, AE Rojek, W Stock Current Treatment Options in Oncology 21, 1-21, 2020 | 27 | 2020 |
| Therapy-related myeloid neoplasms in 109 patients after radiation monotherapy AA Patel, AE Rojek, MW Drazer, H Weiner, LA Godley, MM Le Beau, ... Blood Advances 5 (20), 4140-4148, 2021 | 17 | 2021 |
| CNS prophylaxis during front-line therapy in aggressive non-Hodgkin lymphomas: real-world outcomes and practice patterns from 19 US academic institutions VM Orellana-Noia, DR Reed, JM Sen, C Barlow, MK Malecek, BS Kahl, ... Blood 136, 27-28, 2020 | 15 | 2020 |
| Evolution of therapy for limited stage diffuse large B-cell lymphoma AE Rojek, SM Smith Blood Cancer Journal 12 (2), 33, 2022 | 12 | 2022 |
| Optimizing synchrotron microCT for high-throughput phenotyping of zebrafish PJ La Rivière, D Clark, A Rojek, P Vargas, X Xiao, F DeCarlo, ... Developments in X-Ray Tomography VII 7804, 186-193, 2010 | 9 | 2010 |
| Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHL AE Rojek, JP Kline, N Feinberg, DE Appelbaum, Y Pu, BA Derman, ... Clinical Lymphoma Myeloma and Leukemia 24 (2), 83-93, 2024 | 2 | 2024 |
| Residency Training in the COVID-19 Pandemic—Addressing the Need for Systems-Based Education AE Rojek, PT Schiller JAMA Health Forum 3 (9), e223023-e223023, 2022 | 2 | 2022 |
| tRNA expression and tRFs in multiple myeloma: Progression from monoclonal gammopathies to relapsed/refractory disease AE Rojek, CD Katanski, A Stefka, BA Derman, A Jakubowiak, T Pan Cancer Research 81 (13_Supplement), 2394-2394, 2021 | 2 | 2021 |
| Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Secondary Central Nervous System Large B-Cell Lymphoma (SCNSL): A Multicenter Retrospective Analysis G Ahmed, A Alsouqi, A Szabo, AE Rojek, PA Riedell, FT Awan, L Samples, ... Blood 142, 3088, 2023 | 1 | 2023 |
| Residents as Innovators on COVID-19 Respiratory Isolation Units AE Rojek, PT Schiller Academic Medicine 97 (7), 946-947, 2022 | 1 | 2022 |
| Impact of pre-treatment whole-body metabolic tumor volume on toxicities and outcomes in patients treated with anti-CD19 CAR T-cell therapy for aggressive large B-cell NHL AE Rojek, JP Kline, DE Appelbaum, Y Pu, N Feinberg, BA Derman, ... 2021 TCT| Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, 2021 | 1 | 2021 |
| Heat shock triggers assembly of tRNA synthetases into an active supercomplex J Riback, P Laskowski, JL Scott, EWJ Wallace, AE Rojek, MH Schwartz, ... Biophysical Journal 108 (2), 221a, 2015 | 1 | 2015 |
| LYMPHOMA, MYELOMA LEUKEMIA JS Burton, NC Foley, N Mehta-Shah, H Ma, S O’Brien, P Gupta, AE Rojek, ... | | 2024 |
| Real World Predictors of Response and 24-month survival in high-grade TP53-mutated Myeloid Neoplasms A Kaur, A Rojek, E Symes, AA Patel, MT Nawas, JL Patel, PM Sojitra, ... medRxiv, 2024.03. 11.24303995, 2024 | | 2024 |
| Intensive Induction Chemotherapy with or without Gemtuzumab Ozogamicin Among Patients with Core-Binding Factor Acute Myeloid Leukemia AE Rojek, BJ McCormick, J Cwykiel, O Odetola, Y Abaza, R Achar, ... Blood 142, 2889, 2023 | | 2023 |
